Type 1 diabetes (T1D) belongs among polygenic multifactorial autoimmune diseases. The highest risk is associated with human leucocyte antigen (HLA) class II genes, including HLA-DQA1 gene. Our aim was to investigate DNA methylation of HLA-DQA1 promoter alleles (QAP) and correlate methylation status with individual HLA-DQA1 allele expression of patients with T1D and healthy controls. DNA methylation is one of the epigenetic modifications that regulate gene expression and is known to be shaped by the environment.Sixty one patients with T1D and 39 healthy controls were involved in this study. Isolated DNA was treated with sodium bisulphite and HLA-DQA1 promoter sequence was amplified using nested PCR. After sequencing, DNA methylation of HLA-DQA1 promoter alleles was analysed. Individual mRNA HLA-DQA1 relative allele expression was assessed using two different endogenous controls (PPIA, DRA). We have found statistically significant differences in HLA-DQA1 allele 02:01 expression (PPIA normalization, Pcorr = 0·041; DRA normalization, Pcorr = 0·052) between healthy controls and patients with T1D. The complete methylation profile of the HLA-DQA1 promoter was gained with the most methylated allele DQA1*02:01 and the least methylated DQA1*05:01 in both studied groups. Methylation profile observed in patients with T1D and healthy controls was similar, and no correlation between HLA-DQA1 allele expression and DNA methylation was found. Although we have not proved significant methylation differences between the two groups, detailed DNA methylation status and its correlation with expression of each HLA-DQA1 allele in patients with T1D have been described for the first time.

Department of General Biology and Genetics 3rd Faculty of Medicine Charles University Prague Prague Czech Republic

University Hospital Kralovske Vinohrady Prague Czech Republic

Zobrazit více v PubMed

Gan MJ, Albanese‐O'Neill A, Haller MJ. Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research. Curr Probl Pediatr Adolesc Health Care 2012; 42:269–91. PubMed

Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al Genome‐wide association study and meta‐analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41:703–7. PubMed PMC

Moustakas AK, Papadopoulos GK. Molecular properties of HLA‐DQ alleles conferring susceptibility to or protection from insulin‐dependent diabetes mellitus: keys to the fate of islet beta‐cells. Am J Med Genet 2002; 115:37–47. PubMed

Cerna M. Genetics of autoimmune diabetes mellitus. Wien Med Wochenschr (1946) 2008; 158:2–12. PubMed

Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, et al MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005; 37:486–94. PubMed

Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med 2008; 359:2849–50. PubMed

Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow‐up study. Diabetes 2003; 52:1052–5. PubMed

Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, et al The rising incidence of type 1 diabetes is accounted for by cases with lower‐risk human leukocyte antigen genotypes. Diabetes Care 2008; 31:1546–9. PubMed PMC

Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, et al The rising incidence of childhood type 1 diabetes and reduced contribution of high‐risk HLA haplotypes. Lancet 2004; 364:1699–700. PubMed

Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, et al Identification of type 1 diabetes‐associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011; 7:e1002300. PubMed PMC

Fradin D, Le Fur S, Mille C, Naoui N, Groves C, Zelenika D, et al Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes. PLoS One 2012; 7:e36278. PubMed PMC

Stefan M, Zhang W, Concepcion E, Yi Z, Tomer Y. DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J Autoimmun 2014; 50:33–7. PubMed PMC

Kuroda A, Rauch TA, Todorov I, Ku HT, Al‐Abdullah IH, Kandeel F, et al Insulin gene expression is regulated by DNA methylation. PLoS One 2009; 4:e6953. PubMed PMC

Morzycka‐Wroblewska E, Harwood JI, Smith JR, Kagnoff MF. Structure and evolution of the promoter regions of the DQA genes. Immunogenetics 1993; 37:364–72. PubMed

Britten AC, Mijovic CH, Barnett AH, Kelly MA. Differential expression of HLA‐DQ alleles in peripheral blood mononuclear cells: alleles associated with susceptibility to and protection from autoimmune type 1 diabetes. Int J Immunogenet 2009; 36:47–57. PubMed

Zajacova M, Kotrbova‐Kozak A, Cepek P, Cerna M. Differences in promoter DNA methylation and mRNA expression of individual alleles of the HLA class II DQA1 gene. Immunol Lett 2015; 167:147–54. PubMed

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15:539–53. PubMed

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215. PubMed PMC

Maffei A, Harris PE, Reed EF, Del Pozzo G, Ciullo M, Suciu‐Foca N, et al Differential expression of insulin‐dependent diabetes mellitus‐associated HLA‐DQA1 alleles in vivo . Eur J Immunol 1997; 27:1549–56. PubMed

Donner H, Seidl C, Rau H, Herwig J, Seifried E, Usadel KH, et al Unbalanced amounts of HLA‐DQA1 allele mRNA: DQA1*03 shows high and DQA1*0501 low amounts of mRNA in heterozygous individuals. Eur J Immunogenet 2002; 29:321–30. PubMed

Fernandez S, Wassmuth R, Knerr I, Frank C, Haas JP. Relative quantification of HLA‐DRA1 and ‐DQA1 expression by real‐time reverse transcriptase‐polymerase chain reaction (RT‐PCR). Eur J Immunogenet 2003; 30:141–8. PubMed

Reith W, LeibundGut‐Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005; 5:793–806. PubMed

Ting JP, Trowsdale J. Genetic control of MHC class II expression. Cell 2002; 109(Suppl):S21–33. PubMed

Miao F, Chen Z, Zhang L, Liu Z, Wu X, Yuan YC, et al Profiles of epigenetic histone post‐translational modifications at type 1 diabetes susceptible genes. J Biol Chem 2012; 287:16335–45. PubMed PMC

DiMolfetto L, Neal HA, Wu A, Reilly C, Lo D. The density of the class II MHC T cell receptor ligand influences IFN‐γ/IL‐4 ratios in immune responses in vivo . Cell Immunol 1998; 183:70–9. PubMed

Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, et al HLA DR‐DQ‐encoded genetic determinants of childhood‐onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003; 62:162–9. PubMed

Majumder P, Boss JM. DNA methylation dysregulates and silences the HLA‐DQ locus by altering chromatin architecture. Genes Immun 2011; 12:291–9. PubMed PMC

Scharer CD, Choi NM, Barwick BG, Majumder P, Lohsen S, Boss JM. Genome‐wide CIITA‐binding profile identifies sequence preferences that dictate function versus recruitment. Nucleic Acids Res 2015; 43:3128–42. PubMed PMC

Epigenetic Regulation in Etiology of Type 1 Diabetes Mellitus